title: Randomized trial to evaluate efficacy and safety of combination budesonide and formoterol and new FDA mandate regarding LABAs.
authors.affiliation: University of Tennessee Health Science Center, Memphis, TN, USA.
authors.forename: W Scout
authors.initials: WS
authors.lastname: Robinson
authors.forename: Michael S
authors.initials: MS
authors.lastname: Blaiss
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019819:Budesonide / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004311:Double-Blind Method; D004983:Ethanolamines / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005541:Forced Expiratory Volume; D000068759:Formoterol Fumarate; D006801:Humans; D008297:Male; D036501:Metered Dose Inhalers; D008875:Middle Aged; D009330:Nebulizers and Vaporizers; D010919:Placebos; D012129:Respiratory Function Tests; D013548:Sweden
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D004983:Ethanolamines; D010919:Placebos; D019819:Budesonide; D000068759:Formoterol Fumarate